JPWO2021209601A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021209601A5 JPWO2021209601A5 JP2022543191A JP2022543191A JPWO2021209601A5 JP WO2021209601 A5 JPWO2021209601 A5 JP WO2021209601A5 JP 2022543191 A JP2022543191 A JP 2022543191A JP 2022543191 A JP2022543191 A JP 2022543191A JP WO2021209601 A5 JPWO2021209601 A5 JP WO2021209601A5
- Authority
- JP
- Japan
- Prior art keywords
- anion exchanger
- salt
- wash
- range
- salt solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 150000001450 anions Chemical class 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 9
- 239000012266 salt solution Substances 0.000 description 8
- 239000000356 contaminant Substances 0.000 description 7
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 230000003196 chaotropic effect Effects 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000006167 equilibration buffer Substances 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000011067 equilibration Methods 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
Description
本発明の方法のある実施形態では、第1の塩溶液での洗浄は0.5M~12.0M、又は1M~10M、又は2M~8M、又は4M~6Mの範囲のイオン強度で行うことができる。 In certain embodiments of the method of the present invention, washing with the first salt solution may be performed at an ionic strength ranging from 0.5M to 12.0M , or from 1M to 10M , or from 2M to 8M , or from 4M to 6M .
実施例2.高濃度塩洗浄液の手段による、DNA、タンパク質、mRNAを含むインビトロ転写液からの汚染物質の除去
実施例1に記載したDNA試料に代えてインビトロ転写混合物に置き換えたことを除いて、実施例1の条件を繰り返した。結合しなかった汚染物質は、注入直後にアニオン交換体を通過した。結合した汚染物質を高濃度塩洗浄によってカラムから解離させ、それらを溶離させた。カラム平衡化、試料注入、平衡緩衝液での洗浄、及び高濃度塩水洗浄の主要画分を表すクロマトグラムの部分を図2に示す。高濃度塩水洗浄によって除去された汚染物質は、暗灰色影領域によって示される。図に示すように、洗浄によって除去された汚染物質の量は、実施例1で除去されたDNAの量よりも多い。これは、DNA、dsRNA、及びタンパク質を含むインビトロ転写混合物の汚染物質含量がより高いことの指標である。
Example 2. Removal of contaminants from an in vitro transcription solution containing DNA, protein and mRNA by means of a high salt wash The conditions of Example 1 were repeated, except that the DNA sample described in Example 1 was replaced by an in vitro transcription mixture. Unbound contaminants passed through the anion exchanger immediately after injection. Bound contaminants were dissociated from the column by a high salt wash, which allowed them to be eluted. Portions of the chromatograms representing the main fractions of the column equilibration, sample injection, wash with equilibration buffer and high salt wash are shown in FIG . 2. Contaminants removed by the high salt wash are indicated by the dark grey shaded areas. As can be seen, the amount of contaminants removed by the wash is greater than the amount of DNA removed in Example 1. This is an indication of a higher contaminant content of the in vitro transcription mixture containing DNA, dsRNA and protein.
実施例3.高濃度塩洗浄の間における、強アニオン交換体へのssRNA結合の持続性
200b~6000bの範囲のサイズのssRNAを含有するssRNAラダーを含有する試料に置き換えたことを除いて、実施例1及び2の条件を繰り返した。注射時に結合したssRNAは平衡化緩衝液での洗浄の間結合したままであり、高濃度塩洗浄の間も結合したままであった。UVプロファイルは汚染物質の除去が影付きピークで明らかであった実施例1及び2とは対照的に、ベースラインのプロファイルと厳密に平行である。続いて、ssRNAは65℃の塩勾配で溶出された。
Example 3. Persistence of ssRNA binding to strong anion exchanger during high salt washes The conditions of Examples 1 and 2 were repeated, except that a sample containing a ssRNA ladder containing ssRNA ranging in size from 200b to 6000b was substituted. The ssRNA bound at the time of injection remained bound during the equilibration buffer wash and also during the high salt wash . The UV profile is strictly parallel to the baseline profile, in contrast to Examples 1 and 2, where removal of contaminants was evident in the shaded peaks . The ssRNA was then eluted with a salt gradient at 65°C.
本明細書における明示的教示と不整合がない限りにおいて、本明細書で引用された文献は全て、参照によりその全体が本明細書に組み込まれる。
本願発明の例示的な態様を以下に記載する。
<1>
一本鎖RNAを含む試料をアニオン交換体に適用するステップ、
18℃~25℃の範囲にある第1の温度で、0.5M~12.0Mの範囲にある第1のイオン強度を有する第1の塩溶液を用いて、前記アニオン交換体を洗浄するステップ、及び
35℃~80℃の範囲にある第2の温度で、第2のイオン強度を有する第2の塩溶液によって前記一本鎖RNAを溶出するステップ
を含み、
前記第1のイオン強度が前記第2のイオン強度よりも0.5M以上高いことを前提とする、
アニオン交換体を使用する一本鎖RNA精製方法。
<2>
前記第1の塩溶液を用いる洗浄が1M~10M、又は2M~8M、又は4M~6Mの範囲にあるイオン強度で行われる、<1>に記載の方法。
<3>
前記第1の塩溶液を用いる洗浄がカオトロピック塩を用いて行われる、<1>又は<2>に記載の方法。
<4>
前記カオトロピック塩がグアニジン塩、過塩素酸塩、チオシアン酸塩、又はこれらの混合物からなる群より選択される、<3>に記載の方法。
<5>
前記第1の塩溶液による洗浄が1mM~1000mM、又は5mM~500mM、又は10mM~100mM、又は20mM~50mMの範囲にある濃度のキレート剤を含む、<1>~<4>のいずれか一項に記載の方法。
<6>
前記第1の塩溶液による洗浄がエチレンジアミン四酢酸(EDTA)、又はエチレングリコール-ビス(2-アミノエチルエーテル)-N,N,N’,N’-四酢酸(EGTA)、及びトリス(2-アミノエチル) アミン(TREN)からなる群より選択される一種以上のキレート剤を含む、<1>~<5>のいずれか一項に記載の方法。
<7>
前記一本鎖RNAの溶出に使用される前記第2の塩溶液が45℃~70℃、又は50℃~70℃、又は55℃~70℃、又は60℃~70℃の範囲にある前記第2の温度で適用される、<1>~<6>のいずれか一項に記載の方法。
<8>
前記アニオン交換体が四級アミノイオン交換基を有する強アニオン交換体、三級アミノイオン交換基を有する弱アニオン交換体、二級アミノイオン交換基を有する弱アニオン交換体、一級アミノ基を有する弱アニオン交換体、及び2種以上のアミノ基を有するアニオン交換体からなる群より選択される、<1>~<7>のいずれか一項に記載の方法。
<9>
前記RNAのサイズが1000塩基~25000塩基の範囲である、<1>~<8>のいずれか一項に記載の方法。
Except to the extent inconsistent with an explicit teaching herein, all references cited herein are incorporated by reference in their entirety.
Exemplary embodiments of the present invention are described below.
<1>
applying a sample containing single-stranded RNA to an anion exchanger;
washing the anion exchanger with a first salt solution having a first ionic strength in the range of 0.5 M to 12.0 M at a first temperature in the range of 18° C. to 25° C.; and
Eluting the single-stranded RNA with a second salt solution having a second ionic strength at a second temperature in the range of 35° C. to 80° C.
Including,
Provided that the first ionic strength is at least 0.5 M higher than the second ionic strength.
A method for purifying single-stranded RNA using an anion exchanger.
<2>
The method according to <1>, wherein the washing with the first salt solution is carried out at an ionic strength in the range of 1M to 10M, or 2M to 8M, or 4M to 6M.
<3>
The method according to <1> or <2>, wherein the washing with the first salt solution is carried out using a chaotropic salt.
<4>
The method according to <3>, wherein the chaotropic salt is selected from the group consisting of a guanidine salt, a perchlorate, a thiocyanate, or a mixture thereof.
<5>
The method according to any one of <1> to <4>, wherein the washing with the first salt solution contains a chelating agent at a concentration in the range of 1 mM to 1000 mM, or 5 mM to 500 mM, or 10 mM to 100 mM, or 20 mM to 50 mM.
<6>
The method according to any one of <1> to <5>, wherein the washing with the first salt solution contains one or more chelating agents selected from the group consisting of ethylenediaminetetraacetic acid (EDTA), ethyleneglycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), and tris(2-aminoethyl)amine (TREN).
<7>
The method according to any one of <1> to <6>, wherein the second salt solution used for eluting the single-stranded RNA is applied at the second temperature in the range of 45° C. to 70° C., or 50° C. to 70° C., or 55° C. to 70° C., or 60° C. to 70° C.
<8>
The method according to any one of <1> to <7>, wherein the anion exchanger is selected from the group consisting of a strong anion exchanger having a quaternary amino ion exchange group, a weak anion exchanger having a tertiary amino ion exchange group, a weak anion exchanger having a secondary amino ion exchange group, a weak anion exchanger having a primary amino group, and an anion exchanger having two or more types of amino groups.
<9>
The method according to any one of <1> to <8>, wherein the size of the RNA is in the range of 1,000 bases to 25,000 bases.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20170184.4 | 2020-04-17 | ||
EP20170184.4A EP3896159A1 (en) | 2020-04-17 | 2020-04-17 | A method of single strand rna purification employing an anion exchanger |
PCT/EP2021/059911 WO2021209601A1 (en) | 2020-04-17 | 2021-04-16 | A method of single strand rna purification employing an anion exchanger |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023522526A JP2023522526A (en) | 2023-05-31 |
JPWO2021209601A5 true JPWO2021209601A5 (en) | 2024-04-26 |
Family
ID=70482246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022543191A Pending JP2023522526A (en) | 2020-04-17 | 2021-04-16 | Single-strand RNA purification method using anion exchanger |
Country Status (5)
Country | Link |
---|---|
US (1) | US20230142167A1 (en) |
EP (1) | EP3896159A1 (en) |
JP (1) | JP2023522526A (en) |
CN (1) | CN115087736A (en) |
WO (1) | WO2021209601A1 (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7626017B2 (en) * | 1997-10-31 | 2009-12-01 | Pressure Biosciences, Inc. | Pressure-enhanced extraction and purification |
US8067580B2 (en) * | 2008-02-07 | 2011-11-29 | Ge Healthcare Bio-Sciences Corp. | Isolation of DNA, RNA and protein from a single sample |
CN103993002A (en) * | 2013-02-19 | 2014-08-20 | 百奥迈科生物技术有限公司 | New production process for large-scale synthesis of long-chain RNA drugs |
WO2014144767A1 (en) | 2013-03-15 | 2014-09-18 | Moderna Therapeutics, Inc. | Ion exchange purification of mrna |
SG10202010471UA (en) * | 2016-04-22 | 2020-11-27 | Biontech Rna Pharmaceuticals Gmbh | Methods for providing single-stranded rna |
WO2018096179A1 (en) * | 2016-11-28 | 2018-05-31 | Curevac Ag | Method for purifying rna |
-
2020
- 2020-04-17 EP EP20170184.4A patent/EP3896159A1/en active Pending
-
2021
- 2021-04-16 WO PCT/EP2021/059911 patent/WO2021209601A1/en active Application Filing
- 2021-04-16 CN CN202180013502.6A patent/CN115087736A/en active Pending
- 2021-04-16 JP JP2022543191A patent/JP2023522526A/en active Pending
- 2021-04-16 US US17/918,242 patent/US20230142167A1/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018241214B9 (en) | Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers | |
EP1963504A1 (en) | Method for the extraction of biomolecules from fixed tissues | |
EP3187879B1 (en) | Methods for increasing sensitivity of detection and/or quantification of negatively charged analytes | |
US5801237A (en) | Method for the purification of short nucleic acids | |
Gagnon et al. | Chromatographic behavior of IgM: DNA complexes | |
JP2015503524A5 (en) | ||
EP3157689B1 (en) | Apatite pretreatment | |
CN105407917B (en) | Apatite in situ restoration | |
JPWO2021209601A5 (en) | ||
WO2009076645A1 (en) | Method for nucleic acids isolation | |
US20230151351A1 (en) | A method of single-stranded rna purification | |
ATE449637T1 (en) | MAGNETIC MOLECULES: METHOD USING FUNCTIONALIZED MAGNETIC FERRITINS FOR SELECTIVE REMOVAL OF IMPURITIES FROM SOLUTIONS BY MAGNETIC FILTRATION | |
US20230142167A1 (en) | A method of single strand rna purification employing an anion exchanger | |
CN116261483A (en) | Multimode metal affinity processing capsid | |
JP2001507459A (en) | Regeneration LOMI decontamination process | |
US20230142600A1 (en) | A method of single-stranded rna purification | |
KR20180030861A (en) | Amine analysis by ion chromatography | |
JP2023545998A (en) | Improved removal of RNA and impurities from DNA plasmid preparations by hydrophobic interaction chromatography | |
JPWO2021209595A5 (en) | ||
US20200199573A1 (en) | Polynucleotide Purification Agents and Related Methods | |
Scopes | Biospecific affinity elution | |
Dolan et al. | Separation problems: band tailing and peak distortion | |
Ráczová et al. | New study of anion-exchange chromatography for profiling of soil and peat humic substances and aromatic carboxylic acids | |
CA3029503A1 (en) | Method for isolating nucleic acids with bivalent cations and elution with a cation chelating agent | |
JPWO2021209597A5 (en) |